David Sholehvar - 01 Aug 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: President, Clinical Services
Signature: /s/ Ali Olivo, Attorney-in-Fact
Issuer symbol: NEO
Transactions as of: 01 Aug 2022
Net transactions value: $0
Form type: 4
Filing time: 03 Aug 2022, 17:45:43 UTC
Previous filing: 04 Apr 2022
Next filing: 14 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Award	$0	+12,352	+40%	$0.000000	43,216	01 Aug 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEO	Stock Option (Right to Buy)	Award	$0	+25,826		$0.000000	25,826	01 Aug 2022	Common Stock	25,826	$10.12	Direct	F3
holding	NEO	Stock Option (Right to Buy)						66,372	01 Aug 2022	Common Stock	66,372	$12.15	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 1, 2022, Dr. Sholehvar was granted 12,352 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
F2	On April 1, 2022, Dr. Sholehvar was granted 66,372 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3	On August 1, 2022, Dr. Sholehvar was granted 25,826 stock options. These options vest ratably over the first four anniversary dates of the grant date.